Zydus Wellness Limited (IN:ZYDUSWELL)
:ZYDUSWELL
Want to see IN:ZYDUSWELL full AI Analyst Report?
Top Page
Zydus Wellness Limited
(ZYDUSWELL)
Select Model
Select Model
Rating:53Neutral
Price Target:
₹517.00
▲(21.68% Upside)
Action:Reiterated
Date:05/20/26
The score is held back primarily by weaker profitability and cash conversion in FY2026 alongside higher leverage, despite strong revenue growth. Technicals are supportive with the stock trading above key moving averages, but a high P/E and low dividend yield make the valuation less forgiving.
Positive Factors
Strong Revenue Growth
A sustained +37.9% revenue acceleration in FY2026 indicates meaningful top-line momentum and expanding market penetration. For 2–6 months this supports scale benefits, bargaining power with channels, and opportunities to leverage fixed-cost absorption to restore margins if growth is maintained.
Negative Factors
Margin Compression
A sharp net margin reset from ~12.8% to ~5.0% materially reduces returns on sales and limits internal funding capacity. Unless pricing, mix or cost structure improves, lower profitability can persist and constrain reinvestment, dividend capacity, and long‑term return recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
A sustained +37.9% revenue acceleration in FY2026 indicates meaningful top-line momentum and expanding market penetration. For 2–6 months this supports scale benefits, bargaining power with channels, and opportunities to leverage fixed-cost absorption to restore margins if growth is maintained.
Read all positive factors
Zydus Wellness Limited (ZYDUSWELL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹155.93B
Dividend Yield0.28%
Average Volume (3M)15.16K
Price to Earnings (P/E)20.9
Beta (1Y)0.83
Revenue Growth46.22%
EPS Growth-43.17%
CountryIN
Employees1,008
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)30.39
Shares Outstanding318,160,700
10 Day Avg. Volume9,092
30 Day Avg. Volume15,161
Financial Highlights & Ratios
PEG Ratio-1.59
Price to Book (P/B)2.33
Price to Sales (P/S)3.42
P/FCF Ratio345.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.43
Revenue Forecast (FY)₹52.61B
Zydus Wellness Limited Business Overview & Revenue Model
Company Description
Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drin...
How the Company Makes Money
Zydus Wellness primarily makes money by manufacturing, marketing, and selling branded consumer wellness products to retailers, distributors, and e-commerce channels, generating revenue from the sale of packaged goods at scale. Its core revenue mod...
Zydus Wellness Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
55
Neutral
Cash Flow
41
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.73B | 39.61B | 27.09B | 23.28B | 22.55B | 20.09B |
| Gross Profit | 13.52B | 19.34B | 10.77B | 8.87B | 10.96B | 7.41B |
| EBITDA | 3.58B | 5.02B | 3.99B | 3.08B | 3.32B | 3.55B |
| Net Income | 2.53B | 1.97B | 3.47B | 2.67B | 3.10B | 3.09B |
Balance Sheet | ||||||
| Total Assets | 98.81B | 103.08B | 64.42B | 61.48B | 58.33B | 56.92B |
| Cash, Cash Equivalents and Short-Term Investments | 1.48B | 1.15B | 1.29B | 3.16B | 1.08B | 1.96B |
| Total Debt | 30.42B | 32.03B | 1.88B | 3.29B | 2.97B | 3.87B |
| Total Liabilities | 41.76B | 44.82B | 7.70B | 7.91B | 7.11B | 8.48B |
| Stockholders Equity | 57.06B | 58.26B | 56.72B | 53.58B | 51.23B | 48.44B |
Cash Flow | ||||||
| Free Cash Flow | 235.00M | 393.00M | 3.14B | 2.18B | 467.00M | 1.61B |
| Operating Cash Flow | 931.00M | 1.41B | 3.80B | 2.46B | 917.00M | 2.37B |
| Investing Cash Flow | -28.68B | -29.11B | -2.24B | -1.78B | -849.00M | -859.50M |
| Financing Cash Flow | 28.01B | 27.85B | -1.86B | -257.00M | -1.39B | -2.34B |
Zydus Wellness Limited Technical Analysis
Neutral
424.90
Price Trends
473.81
Positive
447.27
Positive
447.38
Positive
Market Momentum
5.70
Positive
47.25
Neutral
27.64
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ZYDUSWELL, the sentiment is Neutral. The current price of 424.9 is below the 20-day moving average (MA) of 503.59, below the 50-day MA of 473.81, and below the 200-day MA of 447.38, indicating a neutral trend. The MACD of 5.70 indicates Positive momentum. The RSI at 47.25 is Neutral, neither overbought nor oversold. The STOCH value of 27.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:ZYDUSWELL.
Zydus Wellness Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹74.82B | 26.80 | ― | 1.24% | 3.42% | -10.04% | |
64 Neutral | ₹141.19B | 29.09 | ― | 0.26% | 4.43% | 1.60% | |
64 Neutral | ₹74.69B | 18.75 | ― | 0.77% | 11.50% | 9.69% | |
63 Neutral | ₹164.02B | 60.32 | ― | 0.13% | 14.19% | 28.49% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ₹54.54B | 46.45 | ― | 0.45% | 9.25% | -4.88% | |
53 Neutral | ₹155.93B | 20.94 | ― | 0.28% | 46.22% | -43.17% |
* Consumer Defensive Sector Average
IN:ZYDUSWELL
Zydus Wellness Limited
490.10
97.86
24.95%
IN:BECTORFOOD
Mrs. Bector's Food Specialities Ltd.
177.65
-124.65
-41.23%
IN:BIKAJI
Bikaji Foods International Ltd.
654.15
-74.53
-10.23%
IN:FINEORG
Fine Organic Industries Ltd.
4,604.95
-9.64
-0.21%
IN:JYOTHYLAB
Jyothy Labs Limited
203.75
-130.69
-39.08%
IN:PGIL
Pearl Global Industries Limited
1,618.10
344.30
27.03%
Zydus Wellness Limited Corporate Events
Zydus Wellness Launches ‘Saksham Niveshak’ Drive for Unclaimed Dividends
Apr 22, 2026
Zydus Wellness Limited has announced participation in the Investor Education and Protection Fund Authority’s “Saksham Niveshak” second 100 days campaign, running from April 1 to July 9, 2026, aimed at shareholders with unpaid or ...
Zydus Wellness Confirms SEBI-Compliant Share Dematerialisation for March Quarter
Apr 11, 2026
Zydus Wellness Limited has confirmed compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. Based on a certificate from its registrar and transfer agent MUFG Intime Indi...
Zydus Wellness Says Surge in Share Volume Is Market Driven, No Undisclosed Events
Apr 7, 2026
Zydus Wellness Limited has responded to a query from the National Stock Exchange of India regarding a recent significant increase in trading volumes of its equity shares. The company stated that it has complied with all disclosure requirements und...
Zydus Wellness Subsidiary to Appeal Spanish VAT Penalty
Apr 4, 2026
Zydus Wellness Limited disclosed that its step-down wholly owned subsidiary, Comfort Click Limited in the U.K., has received an order from the Spanish Tax Authority alleging unpaid value added tax for the first quarter of 2021. The authority has i...
Zydus Wellness Shares Revised Investor Presentation Ahead of March Conference
Mar 18, 2026
Zydus Wellness Limited has released a revised investor presentation ahead of its Analyst and Institutional Investors’ Conference scheduled for March 18 and 19, 2026. The updated deck has been shared with stock exchanges and uploaded on the c...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.